Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444905) titled 'Evaluation of a Machine Learning-Based Prediction Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma' on Feb. 24.
Study Type: Observational [Patient Registry]
Primary Sponsor: Tongji Hospital
Condition:
HCC - Hepatocellular Carcinoma
Machine Learning
Evaluation
Intervention:
Other: Machine Learning-Based Risk Assessment
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2023
Target Sample Size: 800
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07444905
Published by HT Digital Content Services with permission from Health Daily D...